{"transactions":[{"id":1871825,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-06-01T20:27:18.000Z","date":"2023-05-31","kind":"gift","planned":false,"acquired":false,"shares":26500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These transactions represent bona fide gifts from the Reporting Person to another adult child for which no consideration was paid."}],"balance_after":225316,"source":{"system":"sec-edgar","filing":"0001453687-23-000054","document":"wk-form4_1685651220.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368723000054/wk-form4_1685651220.xml","form_type":"4"}},{"id":1871824,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-06-01T20:27:18.000Z","date":"2023-05-31","kind":"gift","planned":false,"acquired":false,"shares":26500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions represent bona fide gifts from the Reporting Person to an adult child for which no consideration was paid."}],"balance_after":251816,"source":{"system":"sec-edgar","filing":"0001453687-23-000054","document":"wk-form4_1685651220.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368723000054/wk-form4_1685651220.xml","form_type":"4"}},{"id":1871823,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-06-01T20:27:18.000Z","date":"2023-05-30","kind":"gift","planned":false,"acquired":false,"shares":43000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These transactions represent bona fide gifts from the Reporting Person to another adult child for which no consideration was paid."}],"balance_after":278316,"source":{"system":"sec-edgar","filing":"0001453687-23-000054","document":"wk-form4_1685651220.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368723000054/wk-form4_1685651220.xml","form_type":"4"}},{"id":1871822,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-06-01T20:27:18.000Z","date":"2023-05-30","kind":"gift","planned":false,"acquired":false,"shares":43000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions represent bona fide gifts from the Reporting Person to an adult child for which no consideration was paid."}],"balance_after":321316,"source":{"system":"sec-edgar","filing":"0001453687-23-000054","document":"wk-form4_1685651220.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368723000054/wk-form4_1685651220.xml","form_type":"4"}},{"id":2060296,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-01-06T22:15:52.000Z","date":"2023-01-05","kind":"sale","acquired":false,"shares":20,"price":1.1114,"value":22.228,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."}],"balance_after":364316,"source":{"system":"sec-edgar","filing":"0001453687-23-000033","document":"wf-form4_167304333252079.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368723000033/wf-form4_167304333252079.xml","form_type":"4"}},{"id":2060295,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-01-06T22:15:52.000Z","date":"2023-01-05","kind":"sale","acquired":false,"shares":3372,"price":1.1293,"value":3807.9996,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."}],"balance_after":364336,"source":{"system":"sec-edgar","filing":"0001453687-23-000033","document":"wf-form4_167304333252079.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368723000033/wf-form4_167304333252079.xml","form_type":"4"}},{"id":2060294,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-01-06T22:15:52.000Z","date":"2023-01-04","kind":"sale","acquired":false,"shares":11,"price":1.145,"value":12.595,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."}],"balance_after":367708,"source":{"system":"sec-edgar","filing":"0001453687-23-000033","document":"wf-form4_167304333252079.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368723000033/wf-form4_167304333252079.xml","form_type":"4"}},{"id":2060293,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-01-06T22:15:52.000Z","date":"2023-01-04","kind":"sale","acquired":false,"shares":6381,"price":1.1337,"value":7234.1397,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."}],"balance_after":367719,"source":{"system":"sec-edgar","filing":"0001453687-23-000033","document":"wf-form4_167304333252079.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368723000033/wf-form4_167304333252079.xml","form_type":"4"}},{"id":2067122,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-04T22:01:13.000Z","date":"2023-01-02","kind":"grant","acquired":true,"shares":475000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests as to 25% on January 2, 2024. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter."}],"balance_after":475000,"derivative":{"exercise_price":1.13,"expiration_date":"2033-01-01","underlying":"Common Stock","underlying_shares":475000},"source":{"system":"sec-edgar","filing":"0001453687-23-000018","document":"wf-form4_167286962791883.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368723000018/wf-form4_167286962791883.xml","form_type":"4"}},{"id":2067121,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-01-04T22:01:13.000Z","date":"2023-01-02","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2024. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,747 shares of common stock purchased under the Issuer's Employee Stock Purchase Program during the contribution period between September 1, 2021 and February 28, 2022."}],"balance_after":374100,"source":{"system":"sec-edgar","filing":"0001453687-23-000018","document":"wf-form4_167286962791883.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368723000018/wf-form4_167286962791883.xml","form_type":"4"}},{"id":2439949,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-01-07T21:18:26.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":3416,"price":3.0859,"value":10541.4344,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.99 to $3.17. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":268353,"source":{"system":"sec-edgar","filing":"0001453687-22-000033","document":"wf-form4_164159029049282.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368722000033/wf-form4_164159029049282.xml","form_type":"4"}},{"id":2443743,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-01-05T21:34:18.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":340000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests as to 25% on January 3, 2023. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter."}],"balance_after":340000,"derivative":{"exercise_price":3.31,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":340000},"source":{"system":"sec-edgar","filing":"0001453687-22-000020","document":"wf-form4_164141844549022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368722000020/wf-form4_164141844549022.xml","form_type":"4"}},{"id":2443742,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-01-05T21:34:18.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":72000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 3, 2023. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 3, 2026."}],"balance_after":271769,"source":{"system":"sec-edgar","filing":"0001453687-22-000020","document":"wf-form4_164141844549022.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368722000020/wf-form4_164141844549022.xml","form_type":"4"}},{"id":2473350,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-12-14T22:16:39.000Z","date":"2021-12-10","kind":"sale","acquired":false,"shares":4370,"price":2.9869,"value":13052.753,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.94 to $3.0201. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":199769,"source":{"system":"sec-edgar","filing":"0001453687-21-000185","document":"wf-form4_163952018706703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368721000185/wf-form4_163952018706703.xml","form_type":"4"}},{"id":2477228,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-12-10T22:07:28.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 4, 2021, the reporting person was granted performance based restricted stock units for an aggregate of 27,500 shares of the Issuer's common stock (the \"Performance RSUs\"), which were earned based on the achievement of two separate performance conditions related to the Issuer's operating and research and development activities. The compensation committee of the board of directors of the Issuer has determined that the second of the performance conditions has been met, and accordingly 13,750 Performance RSUs vested on December 8, 2021."}],"balance_after":204139,"source":{"system":"sec-edgar","filing":"0001453687-21-000175","document":"wf-form4_163917402992018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368721000175/wf-form4_163917402992018.xml","form_type":"4"}},{"id":2541514,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-15T22:07:41.000Z","date":"2021-10-13","kind":"sale","acquired":false,"shares":3892,"price":4.39,"value":17085.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $4.35 to $4.475. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":190389,"source":{"system":"sec-edgar","filing":"0001453687-21-000143","document":"wf-form4_163433564708644.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368721000143/wf-form4_163433564708644.xml","form_type":"4"}},{"id":2548754,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-05T20:26:20.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 4, 2021, the reporting person was granted performance based restricted stock units for an aggregate of 27,500 shares of the Issuer's common stock (the \"Performance RSUs\"), which may be earned based on the achievement of two separate performance conditions related to the Issuer's operating and research and development activities. Any Performance RSUs will generally vest in two equal installments upon the dates of achievement of each of the two performance conditions, subject to continued employment, so long as each performance condition is met before December 31, 2021. The compensation committee of the board of directors of the Issuer has determined that the first of the performance conditions has been met, and accordingly 13,750 Performance RSUs vested on October 1, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,753 shares of common stock purchased under the Issuer's Employee Stock Purchase Program during the contribution period between March 1, 2021 and August 31, 2021."}],"balance_after":194281,"source":{"system":"sec-edgar","filing":"0001453687-21-000134","document":"wf-form4_163346556411169.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368721000134/wf-form4_163346556411169.xml","form_type":"4"}},{"id":2718509,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-05-11T20:24:20.000Z","date":"2021-05-07","kind":"exercise","acquired":false,"shares":13629,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested as of September 7, 2015."}],"balance_after":0,"derivative":{"exercise_price":2.77,"expiration_date":"2021-09-07","underlying":"Common Stock","underlying_shares":13629},"source":{"system":"sec-edgar","filing":"0001453687-21-000064","document":"wf-form4_162076464438216.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368721000064/wf-form4_162076464438216.xml","form_type":"4"}},{"id":2718508,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-05-11T20:24:20.000Z","date":"2021-05-07","kind":"exercise","acquired":true,"shares":13629,"price":2.77,"value":37752.33,"ownership":{"direct":true},"balance_after":177778,"source":{"system":"sec-edgar","filing":"0001453687-21-000064","document":"wf-form4_162076464438216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368721000064/wf-form4_162076464438216.xml","form_type":"4"}},{"id":2915394,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-01-06T21:50:09.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":230000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests as to 25% on January 4, 2022. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter."}],"balance_after":230000,"derivative":{"exercise_price":2.99,"expiration_date":"2031-01-03","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0001453687-21-000017","document":"wf-form4_160996979617224.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368721000017/wf-form4_160996979617224.xml","form_type":"4"}},{"id":2915393,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-01-06T21:50:09.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 4, 2022. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 4, 2025."}],"balance_after":164149,"source":{"system":"sec-edgar","filing":"0001453687-21-000017","document":"wf-form4_160996979617224.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368721000017/wf-form4_160996979617224.xml","form_type":"4"}},{"id":2999267,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-27T21:13:08.000Z","date":"2020-10-23","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option are fully vested."}],"balance_after":13629,"derivative":{"exercise_price":2.77,"expiration_date":"2021-09-07","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001453687-20-000119","document":"wf-form4_160383317124280.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368720000119/wf-form4_160383317124280.xml","form_type":"4"}},{"id":2999266,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-10-27T21:13:08.000Z","date":"2020-10-23","kind":"exercise","acquired":true,"shares":30000,"price":2.77,"value":83100.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,410 shares of common stock acquired on March 2, 2020 and 3,625 shares of common stock acquired on August 31, 2020, in each case under the issuer's 2016 Employee Stock Purchase Plan."}],"balance_after":126149,"source":{"system":"sec-edgar","filing":"0001453687-20-000119","document":"wf-form4_160383317124280.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368720000119/wf-form4_160383317124280.xml","form_type":"4"}},{"id":3318311,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-07T01:07:51.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest as to 25% on January 2, 2021. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter."}],"balance_after":140000,"derivative":{"exercise_price":2.3,"expiration_date":"2030-01-01","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001453687-20-000012","document":"wf-form4_157835925407457.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368720000012/wf-form4_157835925407457.xml","form_type":"4"}},{"id":3395277,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-10-09T20:20:17.000Z","date":"2019-10-07","kind":"grant","acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest as to 50% of the shares on October 7, 2020, and the remaining 50% of the shares on October 7, 2021."}],"balance_after":180000,"derivative":{"exercise_price":1.75,"expiration_date":"2029-10-06","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001453687-19-000147","document":"wf-form4_157065239599056.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368719000147/wf-form4_157065239599056.xml","form_type":"4"}},{"id":3433131,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-08-20T20:31:50.000Z","date":"2019-08-20","kind":"grant","acquired":true,"shares":50000,"price":1.81,"value":90500.0,"ownership":{"direct":true},"balance_after":86114,"source":{"system":"sec-edgar","filing":"0001453687-19-000122","document":"wf-form4_156633309274523.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368719000122/wf-form4_156633309274523.xml","form_type":"4"}},{"id":3641808,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-02-21T21:29:57.000Z","date":"2019-01-07","kind":"exercise","acquired":false,"shares":36114,"price":2.77,"value":100035.78,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option are fully vested."}],"balance_after":43629,"derivative":{"exercise_price":2.77,"expiration_date":"2021-09-07","underlying":"Common Stock","underlying_shares":36114},"source":{"system":"sec-edgar","filing":"0001676930-19-000002","document":"wf-form4_155078458301932.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000167693019000002/wf-form4_155078458301932.xml","form_type":"4"}},{"id":3641807,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-02-21T21:29:57.000Z","date":"2019-01-07","kind":"exercise","acquired":true,"shares":36114,"price":2.77,"value":100035.78,"ownership":{"direct":true},"balance_after":36114,"source":{"system":"sec-edgar","filing":"0001676930-19-000002","document":"wf-form4_155078458301932.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000167693019000002/wf-form4_155078458301932.xml","form_type":"4"}},{"id":3700103,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-08T21:19:19.000Z","date":"2019-01-07","kind":"grant","acquired":true,"shares":100000,"price":2.6,"value":260000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest as to 25% on January 7, 2020.  The remainder of the underlying shares will vest in 36 equal monthly installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":2.6,"expiration_date":"2029-01-06","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001453687-19-000011","document":"wf-form4_154698234281465.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368719000011/wf-form4_154698234281465.xml","form_type":"4"}},{"id":3888602,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-19T23:07:02.000Z","date":"2018-06-15","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% of the shares on June 15, 2019.  The remainder of the shares will vest in 36 equal monthly installments thereafter."}],"balance_after":50000,"derivative":{"exercise_price":12.75,"expiration_date":"2028-06-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001638599-18-000680","document":"doc4_5477.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859918000680/doc4_5477.xml","form_type":"4"}},{"id":4259039,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-11T20:45:17.000Z","date":"2017-07-07","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 25% of the shares on June 16, 2018.  The remainder of the shares will vest in 36 equal monthly installments thereafter."}],"balance_after":40000,"derivative":{"exercise_price":19.33,"expiration_date":"2027-07-06","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001638599-17-000701","document":"doc4_4845.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859917000701/doc4_4845.xml","form_type":"4"}},{"id":4509709,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-12-30T23:07:37.000Z","date":"2016-12-28","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option are fully vested."}],"balance_after":79743,"derivative":{"exercise_price":2.77,"expiration_date":"2021-09-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-16-164625","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000110465916164625/a4.xml","form_type":"4"}},{"id":4509708,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-12-30T23:07:37.000Z","date":"2016-12-28","kind":"sale","acquired":false,"shares":10000,"price":17.55,"value":175500.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-16-164625","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000110465916164625/a4.xml","form_type":"4"}},{"id":4509707,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":112901,"kind":"person","name":"Kishimoto Takashi Kei","position":1,"cik":"0001676930","reported_name":"Kishimoto Takashi Kei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-12-30T23:07:37.000Z","date":"2016-12-28","kind":"exercise","acquired":true,"shares":10000,"price":2.77,"value":27700.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001104659-16-164625","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000110465916164625/a4.xml","form_type":"4"}}]}